Perrigo acquires ScarAway

DUBLIN — Perrigo has acquired OTC scar management company ScarAway, the company announced Monday. Perrigo expects the brand to bring in $3 million in the remainder of the year, with $10 million in projected full-year net sales. 

 

“We are excited to add this margin-enhancing asset to our already robust U.S. OTC portfolio and believe that by leveraging our unique distribution and customer network, Perrigo is well positioned to accelerate the growth of this brand,” Perrigo CEO Joseph Papa said. “We remain committed to pursuing accretive transactions, such as this one, and to further the execution of our strategy as we continue to deliver superior value for our shareholders."

 

The acquisition is expected to be immediately accretive to the company’s adjusted earnings per share for 2015.